Lupin launches generic contraceptive drug in US
PTI, Apr 7, 2022, 4:54 PM IST
New Delhi: Drug maker Lupin On Thursday said it has launched Merzee capsules, a medication used to prevent pregnancy, in the US market.
The Mumbai-based drug maker has launched the product in the US market under exclusive license, marketing and distribution agreement with Slayback Pharma LLC, Lupin Ltd said in a statement.
Slayback had earlier launched this product in the US in February 2021.
Merzee (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules), 1 mg/20 mcg is a generic equivalent of Allergan Pharmaceuticals’ Taytulla capsules.
As per IQVIA MAT February 2022 data, Norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules, 1 mg/20 mcg had estimated annual sales of USD 90 million in the US.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Mangaluru: Campco opposes WHO’s claim of arecanut being carcinogenic
10 month baby gets new heart, new life
World COPD Day: Know your lung function
As Delhi chokes with dangerous pollution levels, doctors warn of health risks for all
World Diabetes Day 2024: Kasturba Hospital Manipal Hosts Zumba Session at Malpe Beach to Raise Diabetes Awareness
MUST WATCH
Latest Additions
Look forward to being your voice in Parliament: Priyanka to people of Wayanad
NDA-BJP candidates wining UP bypolls proof of people’s faith in PM Modi: Yogi
NDA-BJP candidates wining UP bypolls proof of people’s faith in PM Modi: Yogi
Yashasvi, Rahul score half-centuries as India take commanding 218-run lead against Australia
Ruling Cong sweeps Assembly bypolls in Karnataka, setback to BJP-JD(S) alliance
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.